Disease | hepatitis c |
Symptom | |infection |
Sentences | 498 |
PubMedID- 23087749 | Since hbv and hcv share many risk factors and the same transmission routes, the high prevalence of occult hbv infection reported in patients with chronic hepatitis c, ranging from 6.7% to 91.1%, is not surprising (31, 32). |
PubMedID- 26068212 | Therefore, it is important to document hiv co-infections in regions with high hepatitis chronicity and hiv infection rates . |
PubMedID- 23741761 | Susceptibility factors (including excess hepatic iron, hfe mutations, alcohol consumption, infection with hepatitis c and/or human immunodeficiency viruses, oral estrogen use, smoking, and hepatotoxins e.g., hexachlorobenzene) play a significant role in development of clinical manifestations. |
PubMedID- 24685721 | Background & aims: production of interferon (ifn)-gamma by natural killer (nk) cells is attenuated during chronic infection with hepatitis c virus (hcv). |
PubMedID- 23151512 | Chronic infection with hepatitis c virus (hcv) is an important cause of end stage liver disease worldwide. |
PubMedID- 21526182 | Meanwhile, dqa1*0103 appears to provide protection against chronic active infection with hepatitis c virus . |
PubMedID- 22419005 | infection with the hepatitis c virus (hcv) affects nearly 200 million people in the world. |
PubMedID- 26157746 | Hepatocellular carcinoma (hcc) is a growing clinical problem, being the second leading cause of cancer deaths worldwide (globocan, http://globocan.iarc.fr) and one of the only increasing causes of cancer-related mortality in the u.s.1 in contrast to developing countries in the asia-pacific regions and sub-saharan africa, where hepatitis b virus (hbv) is the major risk factor for hcc, chronic infection with hepatitis c virus (hcv) has been a leading cause of hcc in developed countries2 and is the first indication for liver transplantation for patients with hcc in the u.s.3 worldwide, the world health organization (who) estimates that 3% of the world's population has been infected with hcv and that more than 170 million people are currently chronic carriers of hcv (who, www.who.int). |
PubMedID- 21520209 | We investigated the susceptibility of heparg hepatocytes to in vitro infection with serum-derived hepatitis c virus (hcv) particles (hcvsp) and the potential neutralizing activity of the e1e2-specific monoclonal antibody (mab) d32.10. |
PubMedID- 23168863 | infection with the hepatitis c virus as a risk factor of cardiovascular events in the early years after renal transplantation: a single center study from egypt. |
PubMedID- 25646622 | Along these lines, somewhat discouraging results have recently been reported from a phase i monotherapy trial of the hcv entry inhibitor itx-5061 given for up to 28 days in the setting of established chronic infection with the hepatitis c virus . |
PubMedID- 24580042 | The management of co-infection with hiv and hepatitis c virus (hcv) is complicated by viral and drug-drug interactions, treatment-related side effects, and the poor response to therapy of certain hcv genotypes. |
PubMedID- 23327541 | infection with hepatitis c virus (hcv) is associated with significant morbidity, mortality, and economic burden. |
PubMedID- 22485129 | About 90% of cases of liver cancer in japan are related to infection with hepatitis c or b virus . |
PubMedID- 22291576 | infection with hepatitis c virus was associated with 23,000 deaths from liver cancer (95% ci: 21,000–24,000). |
PubMedID- 20085651 | In addition, studies have implicated sr-bi as a key co-receptor mediating infection with the hepatitis c virus. |
PubMedID- 26236109 | infection with hepatitis c virus (hcv) is a global health problem and it is a leading cause for the development of liver fibrosis, cirrhosis, and hepatocellular carcinoma 1. |
PubMedID- 21994696 | Chronic infection with hepatitis c virus (hcv) is associated with significant liver disease and is therefore an important public health problem. |
PubMedID- 22039483 | For example, chronic infection with hepatitis c virus (hcv) results from reduction of the dimerization of mitochondrial antiviral signaling protein (mavs) by hcv nonstructural (ns) protein ns3/4a protease to levels that are too low to mount strong enough antiviral immune responses . |
PubMedID- 20714004 | infection with hepatitis c virus (hcv) is a worldwide health problem with more than 170 million infected individuals. |
PubMedID- 25331321 | Exclusion criteria: 1) co-infection with hepatitis c virus (hcv); 2) positive serum anti-hbc igm; 3) hbeag positive patients; 4) patients who had received prior antiviral therapy for hbv; 5) patients having stigmata of liver cell failure e.g., ascites, encephalopathy; 6) pregnancy or breast feeding; 7) patients with organ transplants; and 8) patients receiving steroids and/or immunosuppressive drugs. |
PubMedID- 26374068 | infection with hepatitis c, or if that fails, liver transplantation. |
PubMedID- 24478542 | Viral infection with hepatitis c virus (hcv) has a high propensity in becoming chronic and it is the major cause of hepatocellular carcinoma (hcc) worldwide. |
PubMedID- 22585716 | infection with hepatitis c virus (hcv) is a major risk factor for hepatocellular carcinoma (hcc) in india. |
PubMedID- 22893870 | The exclusion criteria included a co-infection with hepatitis c virus or human immunodeficiency virus, a history of taking other antiviral agents for chb, decompensated liver cirrhosis, hcc, and a concurrent use of immunosuppressive drugs or corticosteroids and underlying medical diseases accompanied by ascites such as congestive heart failure. |
PubMedID- 22213804 | infection with the hepatitis c virus is a major health burden worldwide (alter and seeff, 2000; lauer and walker, 2001). |
PubMedID- 25170193 | Chronic infection with hepatitis c virus (hcv) is a leading cause of liver-related morbidity and mortality worldwide and predisposes to liver fibrosis and end-stage liver complications. |
PubMedID- 21914084 | Chronic infection with hepatitis c virus (hcv) can induce insulin resistance (ir) in a genotype-dependent manner and contributes to steatosis, progression of fibrosis and resistance to interferon plus ribavirin therapy. |
PubMedID- 25285757 | Chronic infection with hepatitis c virus (hcv) may lead to b cell activation and transformation into non-hodgkin lymphoma (nhl). |
PubMedID- 23534815 | Objectives: infection with hepatitis c virus (hcv) is a major cause of chronic liver disease. |
PubMedID- 25785448 | Co-infection with hepatitis c virus (hcv) is common in patients with hiv-1 infection and hcv associated liver failure is a leading cause of death in hiv/hcv infected patients 1. |
PubMedID- 25604355 | Although chronic infection with hepatitis c virus (hcv) is the leading indication for liver transplantation in the united states, graft and patient survival rates are reduced because of hcv recurrence after transplant. |
PubMedID- 24342744 | Exclusion criteria included infection with hepatitis c or d viruses or human immunodeficiency virus. |
PubMedID- 26225247 | Chronic infection with hepatitis c virus (hcv) affects about 170 million people worldwide and is a major cause of liver complications. |
PubMedID- 20002561 | infection with the hepatitis c virus commonly occurs in patient groups who have difficulty accessing conventional medical care, reducing their chance of successful antiviral therapy. |
PubMedID- 23710205 | Recently, a retrospective study of 347 first lt recipients (donor or recipient cmv seropositive) transplanted for hcv was performed to evaluate the associations of cmv infection and disease with recurrent hepatitis c after lt. it was found that cmv infection was associated with increased risk of fibrosis stage ≧2 and inflammation grade ≧2 . |
PubMedID- 21760886 | Chronic infection with hepatitis c virus (hcv) is an important cause of liver cancer and end-stage liver disease in the united states and worldwide . |
PubMedID- 25969625 | At the present time, infection with hepatitis c virus (hcv) is a major health problem worldwide and it is the main cause of end stage liver diseases . |
PubMedID- 25314116 | Historically, clinical trials of regimens to treat chronic infection with hepatitis c virus (hcv) have used, as their primary efficacy endpoint, a sustained virological response (svr)-defined as hcv rna levels below a designated threshold of quantification-24 weeks after the end of treatment (svr24). |
PubMedID- 22823899 | Background: persistent infection with hepatitis c virus (hcv) is a leading cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. |
PubMedID- 26189518 | Since the majority of hepatocellular carcinoma (hcc) arises from a background of chronic liver diseases caused by infection with hepatitis c virus (hcv) and hepatitis b virus (hbv), chemoprevention targeting patients at high risk of hcc is feasible. |
PubMedID- 23409973 | infection with hepatitis c virus (hcv) is a global health problem. |
PubMedID- 22911841 | Several factors have been identified as contributing to the excess risk of mortality observed in idus in the cart era including decreased access and adherence to cart , , and more comorbidities such as co-infection with hepatitis c , . |
PubMedID- 22028994 | Hiv infection is linked with hepatitis c infection, which is associated with insulin resistance and diabetes due to increased intrahepatic tumor necrosis factor (tnf-α) and hepatic steatosis. |
PubMedID- 26069796 | Four (4%) had co-infection with hepatitis c virus. |
PubMedID- 23584069 | These effects may be mediated by three general mechanisms:increasing hiv-related mortality directly (e.g., by exacerbating immunosuppression);enhancing the toxicity of art (e.g., by exacerbating the toxic effects of arvs on the liver i.e., hepatotoxicity); andincreasing mortality unrelated to hiv or art (e.g., by accelerating liver damage from concurrent infection with the hepatitis c virus hcv or increasing the likelihood of traumatic injury). |
PubMedID- 22239506 | Commonly known risk factors for infection with hepatitis c virus (hcv) include blood transfusion, injection drug use, intranasal cocaine use, and body tattoos. |
PubMedID- 23626783 | Differential expression of candidate virus receptors in human t lymphocytes prone or resistant to infection with patient-derived hepatitis c virus. |
PubMedID- 26213549 | In conclusion, hepatitis complicated with m. pneumoniae infection is not uncommon and generally has a relatively good prognosis since it showed no significant difference from m. pneumoniae infection as reported in the existing clinical researches. |
PubMedID- 24734095 | Older age, malnutrition and infection with hepatitis c virus and human immunodeficiency virus can also have some effects on reduction of the effectiveness of hbv vaccination (18-21). |